Using Virtual Reality to Help Children with ADHD Improve Executive Functions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to develop a novel rehabilitation method using Virtual Reality (VR) for children aged 8-12 diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). The intervention involves VR games designed to enhance attention and executive functions by simulating real-life situations. Participants will receive parental guidance alongside the VR training to support their rehabilitation process. The study employs a randomized control design to evaluate the effectiveness of this innovative approach.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of ADHD (ICD-10 F90.0) and
* Methylphenidate medication and
* Age 8-12 years and
* Finnish as a native language

Exclusion Criteria:

* Sensitivity to flashing light,
* Epilepsy (ICD-10 G40),
* Mental retardation (ICD-10 F70-F79),
* Pervasive developmental disorders (ICD-10 F84),
* Inflammatory diseases of the central nervous system (ICD-10 G00-G09),
* Severe cerebral palsy syndrome (ICD-10 G80, GMFCS 4-5, MACS 3-5),
* Traumatic brain injury ((ICD-10 S06),
* Brain tumour, and
* Multiple pregnancy

Where it's running

• Oulu University Hospital
  Oulu, Finland Recruiting

Study contacts

• Principal investigator: Merja Nikula, M.Psych. — Oulu University Hospital
• Study coordinator: Merja Nikula, M.Psych.
• Email: merja.nikula@pohde.fi
• Phone: +3588315 5218

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Foquest in older adults with ADHD: daily methylphenidate for 65+

  This study tests whether once-daily Foquest helps symptoms in adults 65 and older with ADHD.

  Recruiting Phase 4 Dar Clinical Research Inc. · Ottawa, Ontario · NCT07710014

• Neuroplasticity-targeted supplements for ADHD in children

  A 12-week randomized trial tests whether gut- and brain-targeted supplements can help reduce ADHD symptoms in children aged 6–12.

  Recruiting Khyber Medical University Peshawar · Peshawar, KPK · NCT07665658

• Therapy approaches for irritability in youths: active treatments vs nonactive psychoeducation

  This study tests whether active psychotherapies for irritability in kids aged 8–16.5 years work better than nonactive, time-matched psychoeducation for children and their parents.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07640802

• Playful physiotherapy to support children with ADHD or autism

  This program will try a play-based physiotherapy approach to see if it improves emotional, behavioral, and social functioning in Estonian-speaking children aged 5–12 with ADHD or autism.

  Recruiting University of Tartu · Tartu · NCT07466147

• Social cognition testing for 8–16-year-olds with autism, ADHD, or atypical development

  This project will test a multidimensional social-cognition battery in French-speaking 8–16-year-olds with autism, ADHD, or atypical neurodevelopment to see if it better identifies social processing differences.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07439276

• Transcranial infrared light to the prefrontal cortex for adults with ADHD

  This trial will try using transcranial infrared light on the prefrontal cortex to see if it improves attention, impulse control, and working memory in adults with ADHD.

  Recruiting University of Texas at Austin · Austin, Texas · NCT07203092

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.